<qa>  To evaluate the pharmacokinetics of glembatumumumabIII. To evaluate the pharmacokinetics PK of glembatumumab vedotin and nivolumab in combination in serum and in mononuclear phagocyte system MPS cells in peripheral blood mononuclear cells. 